These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 22818233)

  • 1. The therapeutic effect of Tarentula cubensis extract (Theranekron®) in foot-and-mouth disease in cattle: a randomised trial in an endemic setting.
    Lotfollahzadeh S; Alizadeh MR; Mohri M; Mokhber Dezfouli MR
    Homeopathy; 2012 Jul; 101(3):159-64. PubMed ID: 22818233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The brown spider Loxosceles laeta: source of the remedy Tarentula cubensis?
    Richardson-Boedler C
    Homeopathy; 2002 Jul; 91(3):166-70. PubMed ID: 12322871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical efficacy of meloxicam (Metacam) and flunixin (Finadyne) as adjuncts to antibacterial treatment of respiratory disease in fattening cattle.
    Friton GM; Cajal C; Ramirez Romero R; Kleemann R
    Berl Munch Tierarztl Wochenschr; 2004; 117(7-8):304-9. PubMed ID: 15298058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A field trial comparing the efficacy of sulphamonomethoxine, penicillin, and tarantula poison in the treatment of pododermatitis circumspecta of cattle.
    Stampa S
    J S Afr Vet Assoc; 1986 Jun; 57(2):91-3. PubMed ID: 3540300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic Foot-and-Mouth Disease Vaccination in Cattle Promotes Specific Antibody-Secreting Cells at the Respiratory Tract and Triggers Local Anamnestic Responses upon Aerosol Infection.
    Pega J; Di Giacomo S; Bucafusco D; Schammas JM; Malacari D; Barrionuevo F; Capozzo AV; Rodríguez LL; Borca MV; Pérez-Filgueira M
    J Virol; 2015 Sep; 89(18):9581-90. PubMed ID: 26157128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
    Grubman MJ
    Biologicals; 2005 Dec; 33(4):227-34. PubMed ID: 16289996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The field effectiveness of routine and emergency vaccination with an inactivated vaccine against foot and mouth disease.
    Elnekave E; Li Y; Zamir L; Even-Tov B; Hamblin P; Gelman B; Hammond J; Klement E
    Vaccine; 2013 Jan; 31(6):879-85. PubMed ID: 23246551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impacts of constrained culling and vaccination on control of foot and mouth disease in near-endemic settings: a pair approximation model.
    Ringa N; Bauch CT
    Epidemics; 2014 Dec; 9():18-30. PubMed ID: 25480131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and risk factors for foot and mouth disease infection in cattle in Israel.
    Elnekave E; van Maanen K; Shilo H; Gelman B; Storm N; Abed El Khaliq M; Sharir B; Berke O; Klement E
    Prev Vet Med; 2016 Aug; 130():51-9. PubMed ID: 27435646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of mucosal immune responses and protection of cattle against direct-contact challenge by intranasal delivery with foot-and-mouth disease virus antigen mediated by nanoparticles.
    Pan L; Zhang Z; Lv J; Zhou P; Hu W; Fang Y; Chen H; Liu X; Shao J; Zhao F; Ding Y; Lin T; Chang H; Zhang J; Zhang Y; Wang Y
    Int J Nanomedicine; 2014; 9():5603-18. PubMed ID: 25506214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy of diclofenac sodium and flunixin meglumine as adjuncts to antibacterial treatment of respiratory disease of calves.
    Guzel M; Karakurum MC; Durgut R; Mamak N
    Aust Vet J; 2010 Jun; 88(6):236-9. PubMed ID: 20553574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Foot-and-mouth disease in North American bison (Bison bison) and elk (Cervus elaphus nelsoni): susceptibility, intra- and interspecies transmission, clinical signs, and lesions.
    Rhyan J; Deng M; Wang H; Ward G; Gidlewski T; McCollum M; Metwally S; McKenna T; Wainwright S; Ramirez A; Mebus C; Salman M
    J Wildl Dis; 2008 Apr; 44(2):269-79. PubMed ID: 18436660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of importation of live ruminants on the epizootiology of foot and mouth disease in Saudi Arabia.
    Abd El-Rahim IH; Asghar AH; Mohamed AM; Fat'hi SM
    Rev Sci Tech; 2016 Dec; 35(3):769-778. PubMed ID: 28332652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The widow spider Latrodectus tredecimguttatus: source of the remedy Tarentula hispanica?
    Richardson-Boedler C
    Br Homeopath J; 2001 Jan; 90(1):44-9. PubMed ID: 11212089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomised field trial to evaluate serological response after foot-and-mouth disease vaccination in Turkey.
    Knight-Jones TJ; Bulut AN; Gubbins S; Stärk KD; Pfeiffer DU; Sumption KJ; Paton DJ
    Vaccine; 2015 Feb; 33(6):805-11. PubMed ID: 25528523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal and spatial distributions of foot-and-mouth disease under three different strategies of control and eradication in Colombia (1982-2003).
    Gallego ML; Perez AM; Thurmond MC
    Vet Res Commun; 2007 Oct; 31(7):819-34. PubMed ID: 17285248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for infection with Foot-and-Mouth Disease virus in a cattle population vaccinated with a non-purified vaccine in Iran.
    Emami J; Rasouli N; McLaws M; Bartels CJ
    Prev Vet Med; 2015 May; 119(3-4):114-22. PubMed ID: 25805320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective immune response to liposome adjuvanted high potency foot-and-mouth disease vaccine in Indian cattle.
    Saravanan P; Sreenivasa BP; Selvan RP; Basagoudanavar SH; Hosamani M; Reddy ND; Nathanielsz J; Derozier C; Venkataramanan R
    Vaccine; 2015 Jan; 33(5):670-7. PubMed ID: 25528522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of an inactivated 3C(pro)-3ABC (mu3ABC) ELISA to differentiate cattle infected with foot and mouth disease virus from vaccinated cattle.
    Srisombundit V; Tungthumniyom N; Linchongsubongkoch W; Lekcharoensuk C; Sariya L; Ramasoota P; Lekcharoensuk P
    J Virol Methods; 2013 Mar; 188(1-2):161-7. PubMed ID: 23305815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of the effects of meloxicam and flunixin meglumine (NSAIDs) as adjunctive therapy on interferon and tumor necrosis factor production in calves suffering from enzootic bronchopneumonia.
    Bednarek D; Zdzisińska B; Kondracki M; Rzeski W; Paduch R; Kandefer-Szerszeń M
    Pol J Vet Sci; 2003; 6(2):109-15. PubMed ID: 12817781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.